Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1997 Jul 1;16(13):3778–3786. doi: 10.1093/emboj/16.13.3778

Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40.

E Hohenester 1, P Maurer 1, R Timpl 1
PMCID: PMC1170001  PMID: 9233787

Abstract

BM-40 (also known as SPARC or osteonectin) is an anti-adhesive secreted glycoprotein involved in tissue remodelling. Apart from an acidic N-terminal segment, BM-40 consists of a follistatin-like (FS) domain and an EF-hand calcium-binding (EC) domain. Here we report the crystal structure at 3.1 A resolution of the FS-EC domain pair of human BM-40. The two distinct domains interact through a small interface that involves the EF-hand pair of the EC domain. Residues implicated in cell binding, inhibition of cell spreading and disassembly of focal adhesions cluster on one face of BM-40, opposite the binding epitope for collagens and the N-linked carbohydrate. The elongated FS domain is structurally related to serine protease inhibitors of the Kazal family. Notable differences are an insertion into the inhibitory loop in BM-40 and a protruding N-terminal beta-hairpin with striking similarities to epidermal growth factor. This hairpin is likely to act as a rigid spacer in proteins containing tandemly repeated FS domains, such as follistatin and agrin, and forms the heparin-binding site in follistatin.

Full Text

The Full Text of this article is available as a PDF (779.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alliel P. M., Perin J. P., Jollès P., Bonnet F. J. Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur J Biochem. 1993 May 15;214(1):347–350. doi: 10.1111/j.1432-1033.1993.tb17930.x. [DOI] [PubMed] [Google Scholar]
  2. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem. 1992 Mar 1;204(2):433–451. doi: 10.1111/j.1432-1033.1992.tb16654.x. [DOI] [PubMed] [Google Scholar]
  3. Bolander M. E., Young M. F., Fisher L. W., Yamada Y., Termine J. D. Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci U S A. 1988 May;85(9):2919–2923. doi: 10.1073/pnas.85.9.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bork P., Downing A. K., Kieffer B., Campbell I. D. Structure and distribution of modules in extracellular proteins. Q Rev Biophys. 1996 May;29(2):119–167. doi: 10.1017/s0033583500005783. [DOI] [PubMed] [Google Scholar]
  5. Doolittle R. F. The multiplicity of domains in proteins. Annu Rev Biochem. 1995;64:287–314. doi: 10.1146/annurev.bi.64.070195.001443. [DOI] [PubMed] [Google Scholar]
  6. Downing A. K., Knott V., Werner J. M., Cardy C. M., Campbell I. D., Handford P. A. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell. 1996 May 17;85(4):597–605. doi: 10.1016/s0092-8674(00)81259-3. [DOI] [PubMed] [Google Scholar]
  7. Engel J., Taylor W., Paulsson M., Sage H., Hogan B. Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry. 1987 Nov 3;26(22):6958–6965. doi: 10.1021/bi00396a015. [DOI] [PubMed] [Google Scholar]
  8. Esch F. S., Shimasaki S., Mercado M., Cooksey K., Ling N., Ying S., Ueno N., Guillemin R. Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol Endocrinol. 1987 Nov;1(11):849–855. doi: 10.1210/mend-1-11-849. [DOI] [PubMed] [Google Scholar]
  9. Fujinaga M., Sielecki A. R., Read R. J., Ardelt W., Laskowski M., Jr, James M. N. Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution. J Mol Biol. 1987 May 20;195(2):397–418. doi: 10.1016/0022-2836(87)90659-0. [DOI] [PubMed] [Google Scholar]
  10. Funk S. E., Sage E. H. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol. 1993 Jan;154(1):53–63. doi: 10.1002/jcp.1041540108. [DOI] [PubMed] [Google Scholar]
  11. Funk S. E., Sage E. H. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2648–2652. doi: 10.1073/pnas.88.7.2648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Girard J. P., Springer T. A. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J Biol Chem. 1996 Feb 23;271(8):4511–4517. doi: 10.1074/jbc.271.8.4511. [DOI] [PubMed] [Google Scholar]
  13. Guermah M., Crisanti P., Laugier D., Dezelee P., Bidou L., Pessac B., Calothy G. Transcription of a quail gene expressed in embryonic retinal cells is shut off sharply at hatching. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4503–4507. doi: 10.1073/pnas.88.10.4503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hemmati-Brivanlou A., Kelly O. G., Melton D. A. Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activity. Cell. 1994 Apr 22;77(2):283–295. doi: 10.1016/0092-8674(94)90320-4. [DOI] [PubMed] [Google Scholar]
  15. Hohenester E., Maurer P., Hohenadl C., Timpl R., Jansonius J. N., Engel J. Structure of a novel extracellular Ca(2+)-binding module in BM-40. Nat Struct Biol. 1996 Jan;3(1):67–73. doi: 10.1038/nsb0196-67. [DOI] [PubMed] [Google Scholar]
  16. Inouye S., Guo Y., Ling N., Shimasaki S. Site-specific mutagenesis of human follistatin. Biochem Biophys Res Commun. 1991 Aug 30;179(1):352–358. doi: 10.1016/0006-291x(91)91377-o. [DOI] [PubMed] [Google Scholar]
  17. Johnston I. G., Paladino T., Gurd J. W., Brown I. R. Molecular cloning of SC1: a putative brain extracellular matrix glycoprotein showing partial similarity to osteonectin/BM40/SPARC. Neuron. 1990 Jan;4(1):165–176. doi: 10.1016/0896-6273(90)90452-l. [DOI] [PubMed] [Google Scholar]
  18. Jones T. A., Zou J. Y., Cowan S. W., Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991 Mar 1;47(Pt 2):110–119. doi: 10.1107/s0108767390010224. [DOI] [PubMed] [Google Scholar]
  19. Kleiman R. J., Reichardt L. F. Testing the agrin hypothesis. Cell. 1996 May 17;85(4):461–464. doi: 10.1016/s0092-8674(00)81245-3. [DOI] [PubMed] [Google Scholar]
  20. Kleywegt G. J., Jones T. A. Where freedom is given, liberties are taken. Structure. 1995 Jun 15;3(6):535–540. doi: 10.1016/s0969-2126(01)00187-3. [DOI] [PubMed] [Google Scholar]
  21. Lane T. F., Iruela-Arispe M. L., Johnson R. S., Sage E. H. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol. 1994 May;125(4):929–943. doi: 10.1083/jcb.125.4.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lane T. F., Sage E. H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 1994 Feb;8(2):163–173. [PubMed] [Google Scholar]
  23. Matzuk M. M., Lu N., Vogel H., Sellheyer K., Roop D. R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature. 1995 Mar 23;374(6520):360–363. doi: 10.1038/374360a0. [DOI] [PubMed] [Google Scholar]
  24. Maurer P., Hohenadl C., Hohenester E., Göhring W., Timpl R., Engel J. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J Mol Biol. 1995 Oct 20;253(2):347–357. doi: 10.1006/jmbi.1995.0557. [DOI] [PubMed] [Google Scholar]
  25. Maurer P., Mayer U., Bruch M., Jenö P., Mann K., Landwehr R., Engel J., Timpl R. High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin). Eur J Biochem. 1992 Apr 1;205(1):233–240. doi: 10.1111/j.1432-1033.1992.tb16773.x. [DOI] [PubMed] [Google Scholar]
  26. Michel U., Farnworth P., Findlay J. K. Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol. 1993 Feb;91(1-2):1–11. doi: 10.1016/0303-7207(93)90248-i. [DOI] [PubMed] [Google Scholar]
  27. Murphy-Ullrich J. E., Lane T. F., Pallero M. A., Sage E. H. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J Cell Biochem. 1995 Feb;57(2):341–350. doi: 10.1002/jcb.240570218. [DOI] [PubMed] [Google Scholar]
  28. Nakamura T., Sugino K., Titani K., Sugino H. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J Biol Chem. 1991 Oct 15;266(29):19432–19437. [PubMed] [Google Scholar]
  30. Patthy L., Nikolics K. Functions of agrin and agrin-related proteins. Trends Neurosci. 1993 Feb;16(2):76–81. doi: 10.1016/0166-2236(93)90021-d. [DOI] [PubMed] [Google Scholar]
  31. Pottgiesser J., Maurer P., Mayer U., Nischt R., Mann K., Timpl R., Krieg T., Engel J. Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). J Mol Biol. 1994 May 13;238(4):563–574. doi: 10.1006/jmbi.1994.1315. [DOI] [PubMed] [Google Scholar]
  32. Raines E. W., Lane T. F., Iruela-Arispe M. L., Ross R., Sage E. H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1281–1285. doi: 10.1073/pnas.89.4.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rao Z., Handford P., Mayhew M., Knott V., Brownlee G. G., Stuart D. The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions. Cell. 1995 Jul 14;82(1):131–141. doi: 10.1016/0092-8674(95)90059-4. [DOI] [PubMed] [Google Scholar]
  34. Rupp F., Payan D. G., Magill-Solc C., Cowan D. M., Scheller R. H. Structure and expression of a rat agrin. Neuron. 1991 May;6(5):811–823. doi: 10.1016/0896-6273(91)90177-2. [DOI] [PubMed] [Google Scholar]
  35. Sage E. H., Bassuk J. A., Yost J. C., Folkman M. J., Lane T. F. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence. J Cell Biochem. 1995 Jan;57(1):127–140. doi: 10.1002/jcb.240570113. [DOI] [PubMed] [Google Scholar]
  36. Sage E. H. Terms of attachment: SPARC and tumorigenesis. Nat Med. 1997 Feb;3(2):144–146. doi: 10.1038/nm0297-144. [DOI] [PubMed] [Google Scholar]
  37. Schwarzbauer J. E., Spencer C. S. The Caenorhabditis elegans homologue of the extracellular calcium binding protein SPARC/osteonectin affects nematode body morphology and mobility. Mol Biol Cell. 1993 Sep;4(9):941–952. doi: 10.1091/mbc.4.9.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Shibanuma M., Mashimo J., Mita A., Kuroki T., Nose K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem. 1993 Oct 1;217(1):13–19. doi: 10.1111/j.1432-1033.1993.tb18212.x. [DOI] [PubMed] [Google Scholar]
  39. Tillet E., Wiedemann H., Golbik R., Pan T. C., Zhang R. Z., Mann K., Chu M. L., Timpl R. Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI. Eur J Biochem. 1994 Apr 1;221(1):177–185. doi: 10.1111/j.1432-1033.1994.tb18727.x. [DOI] [PubMed] [Google Scholar]
  40. Xie R. L., Long G. L. Role of N-linked glycosylation in human osteonectin. Effect of carbohydrate removal by N-glycanase and site-directed mutagenesis on structure and binding of type V collagen. J Biol Chem. 1995 Sep 29;270(39):23212–23217. doi: 10.1074/jbc.270.39.23212. [DOI] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES